Benzinga - Polygon (CRYPTO: MATIC) Labs, the primary developer of the Polygon blockchain ecosystem, has announced the discontinuation of ‘Polygon Edge,’ the software used for constructing Dogechain. Polygon Labs is now concentrating its efforts on ‘Polygon CDK,’ a blockchain framework built on zero-knowledge cryptography.
What Happened: According to a report by Coindesk on Thursday, Polygon Labs has stopped contributing to Polygon Edge, the open-source software utilized for creating Ethereum (CRYPTO: ETH) compatible networks. This software served as the foundation for Dogechain, a project to integrate DeFi into the Dogecoin (CRYPTO: DOGE) community.
Polygon Labs revealed in a blog post that its support for chain development within the Polygon ecosystem has transitioned to the Polygon CDK. This new framework, powered by zero-knowledge cryptography (“ZK”), is designed for building layer-2 blockchains.
See Also: Cathie Wood Sheds Coinbase Shares, Bitcoin Faces Downturn, And Shiba Inu Sees Supply Shrinkage: Top Crypt
Several initiatives, including Immutable, Astar, Canto, Gnosis Pay, and Manta Network, have pledged to use the Polygon CDK. Moreover, Polygon Labs is working on transitioning the Celo blockchain to a layer-2 network and is developing a new layer-2 network for the crypto exchange Kraken.
Why It Matters: Dogechain, which was started last year by developers linked to the Dogecoin community, used Polygon Edge as its open-source software template. Despite this, the project did not have the backing of leading figures within the Dogecoin community.
It remains uncertain how Polygon Labs’ decision will affect the operations and future plans of Dogechain. Polygon Labs has noted that while many projects began with Polygon Edge, many are expected to transition to the Polygon CDK.
Read Next: ‘Dogecoin Killer’ Shiba Inu Positioned For Major Bullish Breakout, Says Prominent Crypto Analyst — But It
Disclaimer: This content was partially produced with the help of Benzinga Neuro and was reviewed and published by Benzinga editors.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.